Anúncio
Anúncio
GYRE
Gyre Therapeutics, Inc. Common Stock
7.41
USDPatrocinado
-0.16
-2.11%
09 de jan., 15:57 UTC -5
Encerrado
Pós-Mercado
7.41
0.00
0.00%
Relatórios de Lucros GYRE
Rácio de surpresa positiva
GYRE separação 16 de 33 últimas estimativas.
48%
Próximo Relatório
Data do Próximo Relatório
18 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$37.03M
/$0.05
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+21.15%
/-37.50%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+32.86%
/--
Gyre Therapeutics, Inc. Common Stock earnings per share and revenue
On 07 de nov. de 2025, GYRE reported earnings of 0.08 USD per share (EPS) for Q3 25, beating the estimate of 0.02 USD, resulting in a 194.12% surprise. Revenue reached 30.56 milhão, compared to an expected 33.59 milhão, with a -9.00% difference. The market reacted with a -1.77% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of 0.05 USD, with revenue projected to reach 37.03 milhão USD, implying an diminuir of -37.50% EPS, and aumentar of 21.15% in Revenue from the last quarter.
FAQ
What were Gyre Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Gyre Therapeutics, Inc. Common Stock reported EPS of $0.08, beating estimates by 194.12%, and revenue of $30.56M, -9% below expectations.
How did the market react to Gyre Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.77%, changed from $7.34 before the earnings release to $7.21 the day after.
When is Gyre Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 18 de fev. de 2026.
What are the forecasts for Gyre Therapeutics, Inc. Common Stock's next earnings report?
Based on 5
analistas, Gyre Therapeutics, Inc. Common Stock is expected to report EPS of $0.05 and revenue of $37.03M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio